R&D Changing Faces: Boards of Directors and Advisory Boards – Ap... Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.
R&D Changing Faces: Board of Directors and Advisory Boards, Marc... Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.
R&D Changing Faces: Board of Directors and Advisory Boards, Febr... Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.
R&D Changing Faces: Board of Directors, January 2026 January was a relatively quiet month for Board news, but there were some notable moves here and there.
R&D Changing Faces: Board appointments, November and December 20... As 2025 came to a close, we also saw a modest number of Board appointments, on both advisory and governance Boards.
R&D Changing Faces – Board of Directors and Advisory Boards - Oc... From high-profile resignations to the addition of seasoned executives and scientific leaders, last month saw a series of notable changes.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.